Novonesis (Novozymes) B
NSISBC
Rang in aandelen
#1144
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Aandeelprijs
$71.20
Marktkapitalisatie
$19.79B
Verandering (1 dag)
1.56%
Verandering (1 jaar)
12.29%
Land
DK
Handel Novonesis (Novozymes) B (NSISBC)
Categorie
Basic Materials
Koersgeschiedenis voor Novonesis (Novozymes) B (NSISBC)
Hoogste slotkoers: $69.83 op 2026-10-01
Laagste slotkoers: $58.74 op 2024-03-01
Laagste slotkoers: $58.74 op 2024-03-01
Koersgeschiedenis van Novonesis (Novozymes) B van 2024 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 1.89% |
| 2025 | 7.42% |
| 2024 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $504.45 | 12.12% |
GB
|
|
| $194.75 | 7.01% |
FR
|
|
| $343.16 | 2.80% |
US
|
|
| $291.85 | 5.74% |
US
|
|
| $304.24 | 20.18% |
US
|
